274
Participants
Start Date
November 30, 2008
Primary Completion Date
October 31, 2009
Study Completion Date
November 30, 2009
Placebo
placebo pramlintide and placebo metreleptin twice daily
Pramlintide and Metreleptin
Subcutaneous injection, twice daily
Research Site, Birmingham
Research Site, Phoenix
Research Site, Santa Rosa
Research Site, Walnut Creek
Research Site, Denver
Research Site, Jacksonville
Research Site, Miami
Research Site, Plantation
Research Site, Atlanta
Research Site, Chicago
Research Site, Springfield
Research Site, Kansas City
Research Site, Baton Rouge
Research Site, Boston
Research Site, Edina
Research Site, St Louis
Research Site, Butte
Research Site, New York
Research Site, Cincinnati
Research Site, Columbus
Research Site, Eugene
Research Site, Medford
Research Site, Anderson
Research Site, Greer
Research Site, Mt. Pleasant
Research Site, Nashville
Research Site, Austin
Research Site, Dallas
Research Site, San Antonio
Research Site, Salt Lake City
Research Site, Norfolk
Research Site, Bellingham
Research Site, Olympia
Lead Sponsor
AstraZeneca
INDUSTRY